Japanese Pharmaceuticals & Biotech Top Stock Picks from Analysts

Daiichi Sankyo Company

Market Cap: JP¥5.9t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

PeptiDream

Market Cap: JP¥233.3b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Towa Pharmaceutical

Market Cap: JP¥122.7b

Researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan.

Takara Bio

Market Cap: JP¥93.8b

Engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally.

GNI Group

Market Cap: JP¥89.9b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Nxera Pharma

Market Cap: JP¥70.5b

Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥51.4b

A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.

JCR Pharmaceuticals

Market Cap: JP¥51.0b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

Fuji Pharma

Market Cap: JP¥32.2b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

Japan Tissue Engineering

Market Cap: JP¥18.2b

Engages in the regenerative medicine business in Japan.

StemRIM

Market Cap: JP¥17.5b

A biotechnology company, develops regeneration medicines for the treatment of intractable diseases.

RaQualia Pharma

Market Cap: JP¥7.3b

Engages in the research and development of pharmaceutical compounds worldwide.

Solasia Pharma K.K

Market Cap: JP¥7.2b

Engages in the development and marketing of oncology drugs in Japan and other Asian countries.

Kidswell Bio

Market Cap: JP¥5.8b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

TMS

Market Cap: JP¥5.7b

Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.